Rafael Stryjer

Dehydroepiandrosterone Augmentation in the Management of Negative, Depressive, and Anxiety Symptoms in Schizophrenia

Rael D. Strous, Rachel Maayan, Raya Lapidus et al. · Archives of General Psychiatry · 2003 · 200 citations

Amantadine as augmentation therapy in the management of treatment-resistant depression

Rafael Stryjer, Rael D. Strous, Ginette Shaked et al. · International Clinical Psychopharmacology · 2003 · 102 citations

Psychoactive Drug, Psychiatry, Psychotropic Medication +15

Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: A randomized, double-blind placebo controlled trial

Rael D. Strous, Rafael Stryjer, Rachel Maayan et al. · Psychoneuroendocrinology · 2007 · 80 citations

Neuropsychology, Psychiatry, Psychotic Disorder +13

Clozapine in the Treatment of Obsessive-compulsive Symptoms in Schizophrenia Patients: A Case Series Study

Ilya Reznik, I Yavin, Rafael Stryjer et al. · Pharmacopsychiatry · 2004 · 63 citations

Anxiety in the First Attack of Vertigo

Lea Pollak, Colin Klein, Rafael Stryjer et al. · Otolaryngology · 2003 · 63 citations